Stereotaxis, Inc. (STXS) Stock
Healthcare · Medical Instruments & Supplies · Member of Other US Stocks
Stereotaxis, Inc. (STXS) closed at USD 1.05 on 2026-10-15, a change of -64 % over the past year, with a market capitalization of USD 101.2M.
Stereotaxis, Inc. recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-15 | 1.05 |
| 2026-10-14 | 1.05 |
| 2026-10-13 | 1.06 |
| 2026-10-12 | 1.14 |
| 2026-10-09 | 1.11 |
| 2026-10-08 | 1.11 |
| 2026-10-07 | 1.13 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
Stereotaxis, Inc. key figures
- Previous close
- USD 1.05 (2026-10-15)
- 1-year change
- -64 %
- Market cap
- USD 101.2M
- Enterprise value
- USD 101.12M
- P/E ratio (trailing)
- -4.21
- P/E ratio (forward)
- -6.52
- EPS (trailing)
- -0.24
- EPS (forward)
- -0.16
- PEG ratio
- 1.31
- Price to book
- 8.08
- Revenue growth
- -12.8 %
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.00
- Short ratio
- 10.85
- Employees
- 131
- Analyst consensus (third-party)
- none
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for Stereotaxis, Inc. and compare it with other stocks.
Analyze STXSAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Stereotaxis, Inc. shares.